IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of huma
暂无分享,去创建一个
A. Mouraux | R. Treede | I. Tracey | L. Garcia-Larrea | E. Pogatzki-Zahn | N. Finnerup | K. Phillips | J. Vollert | V. Wanigasekera | K. Vincent | A. Truini | G. Di Stefano | O. Caspani | C. Leone | I. Trocóniz | S. Chapman | M. Wittayer | A. Schilder | P. Bloms-Funke | M. Goetz | I. Boesl | G. di Pietro | Tom Li | Bernhard Pelz | Erik Schnetter | Karin Schubart | Hans Van Niel | Jose Miguel Vela Hernandez | Sonya C. Chapman | Tom Li
[1] A. Mouraux,et al. The N13 spinal component of somatosensory evoked potentials is modulated by heterotopic noxious conditioning stimulation suggesting an involvement of spinal wide dynamic range neurons , 2021, Neurophysiologie Clinique.
[2] A. Mouraux,et al. How different experimental models of secondary hyperalgesia change the nociceptive flexion reflex , 2021, Clinical Neurophysiology.
[3] A. Mouraux,et al. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG) , 2021, Trials.
[4] A. Mouraux,et al. Human surrogate models of central sensitization: A critical review and practical guide , 2021, European journal of pain.
[5] S. Dib-Hajj,et al. Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial , 2019, Brain : a journal of neurology.
[6] J. Schüttler,et al. Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors , 2018, EBioMedicine.
[7] Andrew S.C. Rice,et al. Pain and the global burden of disease , 2016, Pain.
[8] A. Filipe,et al. Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Study of Two Formulations of Pregabalin 300 mg Hard Capsules in Healthy Volunteers Under Fasting Conditions , 2015, Drugs in R&D.
[9] A. Płotka,et al. Pharmacokinetics of Pregabalin Controlled-Release in Healthy Volunteers: Effect of Food in Five Single-Dose, Randomized, Clinical Pharmacology Studies , 2014, Clinical Drug Investigation.
[10] A. Vinik,et al. A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy , 2014, Diabetes Care.
[11] W. Cawello,et al. Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: Saliva as a surrogate of pharmacokinetics in the central compartment , 2013, Epilepsia.
[12] W. Cawello,et al. Bioequivalence of Intravenous and Oral Formulations of the Antiepileptic Drug Lacosamide , 2012, Pharmacology.
[13] R. Treede,et al. Analysis of hyperalgesia time courses in humans after painful electrical high-frequency stimulation identifies a possible transition from early to late LTP-like pain plasticity , 2011, PAIN®.
[14] S. Schwartz,et al. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial , 2010, Current medical research and opinion.
[15] G. McCleane. Lacosamide for pain , 2010, Expert opinion on investigational drugs.
[16] B. Corrigan,et al. Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers , 2010, Journal of clinical pharmacology.
[17] D. Ziegler,et al. Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy , 2010, Diabetes Care.
[18] Stefan Knecht,et al. Pain sensitivity can be assessed by self-rating: Development and validation of the Pain Sensitivity Questionnaire , 2009, PAIN.
[19] J. Selam,et al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. , 2009, The journal of pain : official journal of the American Pain Society.
[20] S. Bongardt,et al. Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain: An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens , 2009, The Clinical journal of pain.
[21] W. Brannath,et al. A graphical approach to sequentially rejective multiple test procedures , 2009, Statistics in medicine.
[22] J. Kroin,et al. Can a Single Dose of 300 mg of Pregabalin Reach Acute Antihyperalgesic Levels in the Central Nervous System? , 2008, Regional Anesthesia & Pain Medicine.
[23] Y. Daali,et al. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. , 2007, Clinical therapeutics.
[24] V. Biton,et al. Lacosamide in Painful Diabetic Peripheral Neuropathy: A Phase 2 Double-blind Placebo-controlled Study , 2007, The Clinical journal of pain.
[25] Mariano Serrao,et al. The lower limb flexion reflex in humans , 2005, Progress in Neurobiology.
[26] G. Cruccu,et al. The clinical use of brainstem reflexes and hand-muscle reflexes , 2000, Clinical Neurophysiology.
[27] F. Mauguière,et al. The contribution of median nerve SEPs in the functional assessment of the cervical spinal cord in syringomyelia. A study of 24 patients. , 1991, Brain : a journal of neurology.
[28] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[29] J. Willer. Studies on pain. Effects of morphine on a spinal nociceptive flexion reflex and related pain sensation in man , 1985, Brain Research.
[30] J. Kimura,et al. Disorder of interneurons in Parkinsonism. The orbicularis oculi reflex to paired stimuli. , 1973, Brain : a journal of neurology.
[31] J. Sandkühler,et al. Perceptual Correlates of Nociceptive Long-term Potentiation and Long-term Depression in Humans , 2003 .
[32] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[33] Scott R. Bishop,et al. The Pain Catastrophizing Scale: Development and validation. , 1995 .
[34] M. Johnston,et al. Measures in Health Psychology: A User's Portfolio , 1995 .
[35] C. Spielberger,et al. Manual for the State-Trait Anxiety Inventory , 1970 .